Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
The University of North Carolina at Chapel Hill Newborn Critical Care Center, Chapel Hill, North Carolina Novant Health New Hanover Regional Medical Center, Wilmington, North Carolina